Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.018162563491075.9043
Domestic EquitiesLupin Limited7.36122883991608.3779
Domestic EquitiesDivi's Laboratories Limited6.5803850754543.8445
Domestic EquitiesCipla Limited6.39113495054528.2075
Domestic EquitiesDr. Reddy's Laboratories Limited6.02433916074497.8896
Domestic EquitiesApollo Hospitals Enterprise Limited5.5285648795456.9139
Domestic EquitiesVijaya Diagnostic Centre Limited3.70582886684306.2772
Domestic EquitiesMedPlus Health Services Limited3.54313627277292.8301
Domestic EquitiesAjanta Pharma Limited3.2140959323265.6269
Domestic EquitiesSai Life Sciences Limited2.80912555745232.1639
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.7333913226225.8956
Domestic EquitiesAbbott India Limited2.605474187215.3278
Domestic EquitiesAurobindo Pharma Limited2.43711702630201.4211
Domestic EquitiesThyrocare Technologies Limited2.36864392120195.7568
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.2010999649181.9061
Domestic EquitiesDr. Lal Path Labs Limited2.18541218224180.6139
Domestic EquitiesAlkem Laboratories Limited2.1566323678178.2333
Domestic EquitiesNarayana Hrudayalaya Limited2.1151923911174.8040
Domestic EquitiesIPCA Laboratories Limited2.05021194164169.4399
Domestic EquitiesMankind Pharma Limited2.0132757496166.3840
Domestic EquitiesPfizer Limited1.9206318249158.7331
Domestic EquitiesGland Pharma Limited1.6680800549137.8545
Domestic EquitiesSuraksha Diagnostic Limited1.27123896349105.0651
Domestic EquitiesEmcure Pharmaceuticals Limited1.2322746337101.8377
Domestic EquitiesFortis Healthcare Limited1.1807110388997.5838
Domestic EquitiesSanofi Consumer Healthcare India Limited1.168521365996.5717
Domestic EquitiesSanofi India Limited1.138823027294.1168
Domestic EquitiesMax Healthcare Institute Limited1.127189134093.1539
Domestic EquitiesSyngene International Limited1.0874138049289.8700
Domestic EquitiesBiocon Limited1.0578221937487.4211
Domestic EquitiesAnthem Biosciences Limited0.8344105850368.9615
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8313151526468.7021
Domestic EquitiesAstraZeneca Pharma India Limited0.68356256856.4926
Domestic EquitiesIndoco Remedies Limited0.5209183492443.0473
Domestic EquitiesOrchid Pharma Limited0.420245756134.7266
Domestic EquitiesConcord Biotech Limited0.181911173815.0355
Total 97.3657 8046.9916
Cash & Cash Equivalents and Net AssetsTriparty Repo1.6417 135.6829
Cash & Cash Equivalents and Net AssetsNet Current Assets0.9829 81.2379
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0096 0.7975
Total 2.6343 217.7183
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.